Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome
Journal of Developmental Biology · 02.05.2026 · 14 (2) · 20
DOI: 10.3390/jdb14020020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Developmental Biology, online erschienen am 02.05.2026. Verfasst von Martina Contestabile und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, 56126 Pisa, Italy. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione e del Merito, Angelman Syndrome Alliance (ASA), PRIN.
Abstract (Originalsprache)
Angelman syndrome (AS) is a neurodevelopmental disorder caused by the loss of maternal UBE3A expression, leading to disrupted proteostasis and synaptic dysfunction. Adenosine is a ubiquitous neuromodulator whose G protein-coupled receptors (ARs) regulate neuronal differentiation and neurite outgrowth during development. Here, we investigated AR signaling and their influence on survival–autophagy balance and neuronal morphology in an AS cellular model. Using SH-SY5Y cells with silenced UBE3A, we found that UBE3A loss markedly decreased A1AR, A2BAR, and A3AR protein levels while significantly increasing A2AR expression. Ligand affinity was preserved across genotypes, but A1AR and A2AAR desensitization kinetics were significantly slower in UBE3A-deficient cells. These effects were associated with reduced recruitment of G protein-coupled receptor kinase 2 (GRK2) to the plasma membrane and decreased GRK2–AR association in UBE3A-deficient cells, suggesting a possible contribution of altered GRK2 dynamics to prolonged AR signaling. Functionally, A1AR and A2AR agonists preferentially promoted survival of UBE3A-deficient cells and modulated the MDM2–p53 axis and autophagy markers; A1R stimulation also increased neurite density in UBE3A-deficient cells. Together, these results identify AR-level alterations and defective desensitization machinery in AS neuronal cells and link receptor changes to downstream proteostasis and morphological phenotypes relevant to AS pathophysiology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Istituto Nanoscienze, Consiglio Nazionale delle Ricerche (CNR), @NEST-SNS, Piazza San Silvestro 12, 56127 Pisa, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
ORCID-Profile: Martina Contestabile, Chiara De Cesari, Ilaria Tonazzini, Paolo Giovanni Artini, Simona Daniele
Förderung
- Ministero dell'Istruzione e del Merito
- Angelman Syndrome Alliance (ASA)
- PRIN
Zitieren
APA
Contestabile, M., Martins de Almeida, J. F., De Cesari, C., Tonazzini, I., Artini, P. G., & Daniele, S. (2026). Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome. Journal of Developmental Biology, 14(2), 20. https://doi.org/10.3390/jdb14020020
Vancouver
Contestabile M, Martins de Almeida JF, De Cesari C, Tonazzini I, Artini PG, Daniele S. Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome. Journal of Developmental Biology. 2026;14(2):20. doi:10.3390/jdb14020020
BibTeX
@article{Contestabile2026,
author = {Contestabile, Martina and Martins de Almeida, Jacqueline Fátima and De Cesari, Chiara and Tonazzini, Ilaria and Artini, Paolo Giovanni and Daniele, Simona},
title = {Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome},
journal = {Journal of Developmental Biology},
year = {2026},
volume = {14},
number = {2},
pages = {20},
doi = {10.3390/jdb14020020}
}
EUVIMED